Abstract: The increasing interest from research agencies, governments, and universities in understanding research funding and prioritising research efforts has highlighted the need for reliable and ...

As the nutraceuticals industry continues to expand its definition of cognitive health in response to strong consumer demand, ingredients that support stress regulation, mental clarity, and sustained ...

Hello, and thank you for standing by. At this time, I would like to welcome everyone to the CareDx Investor Webinar Call. [Operator Instructions] I would now like to turn the conference over to ...

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of ...

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of ...

NEW YORK – Personalized cancer firm Artera this week presented four studies on its multimodal artificial intelligence (MMAI) digital pathology-based risk stratification platform at the annual ...

Health care leaders may want to keep a closer eye on clinical validation for artificial intelligence (AI)-enabled medical devices (AIMDs), based on a recent JAMA Health Forum study. The study examined ...

For any document version listed below, click on its file name to view it. The current [ ] version of the document is downloaded by default when the document is referenced elsewhere on the site.

Copyright: © 2025 The Author(s). Published by Elsevier Ltd.

Artificial intelligence-enabled medical devices with no clinical validation were more likely to be the subject of recalls, according to a study published in JAMA Health Forum. The study, published on ...